Key statistics
On Friday, Innate Pharma SA (IDD:DUS) closed at 1.49, 7.50% above its 52-week low of 1.39, set on Feb 23, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.49 |
|---|---|
| High | 1.49 |
| Low | 1.49 |
| Bid | -- |
| Offer | -- |
| Previous close | 1.47 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 93.74m |
| Free float | 68.42m |
| P/E (TTM) | -- |
| Market cap | 137.24m EUR |
| EPS (TTM) | -0.5497 EUR |
Data delayed at least 15 minutes, as of Feb 27 2026 07:11 GMT.
More ▼
Press releases
- Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
- Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
- Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025
- Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
- Innate Pharma Releases Its 2026 Financial Calendar
More ▼
